Anti-FKN mAb E6011 inhibited recruitment immune cells by blocking the FKN–CX3CR1 axis, which was expected to be useful for Crohn’s disease (CD), RA, and PBC (97). This evidence concerns the gene CX3CL1 and rheumatoid arthritis.